German health reform targets long‑term patient benefits to curb €21.6 billion sickness‑bill
Executive summary: German health insurers reported that sickness benefit costs reached €21.6 billion, prompting the government to consider new regulations that would limit benefits for long‑term patients. The proposal directly affects a major cost driver in the statutory health insurance system and could alter out‑of‑pocket expenses for chronically ill patients.
Who is involved: Statutory health insurance funds, the German Ministry of Health, patient advocacy groups, and long‑term care providers.
Likely next: Legislative committees are expected to debate the amendment in the Bundestag later this year, with a possible vote before the end of 2026.
Der Spiegel reports that statutory health insurance funds face rising sickness‑benefit expenditures of €21.6 billion, prompting policymakers to consider new rules that would reduce benefits for long‑term patients. The move reflects broader efforts to contain health‑care costs amid fiscal pressure, but risks increasing financial strain on chronically ill individuals. Experts warn that such cost‑shifting could exacerbate existing inequities in the German health‑care system.
Timeline
- — Gesundheitsreform: Geplante Neuregelung könnte Druck auf Langzeitpatienten erhöhen (Der Spiegel — Wirtschaft)
- — Sécurité sociale : la crainte d’un tour de vis pendant l’été (Le Monde — Économie)
Analysis — what this means
Sectors affected
- German statutory health insurance (GKV)
- Long‑term care sector
- Pharmaceutical industry
Regulatory implications
- Potential amendment to Social Code Book V (SGB V) to cap sickness benefits for long‑term patients
Historical parallels
- 2004 Gesundheitsmodernisierungsgesetz (GMG) increased patient co‑payments and introduced contribution rate adjustments
- 2015 healthcare reform introduced additional contributions for high earners to stabilize GKV finances
Sources
Open the full interactive case file on Beyond →
INTELLIGENCE
Social Pulse
AI estimate · not scraped